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Abstract
New normal linear modeling strategies are presented for analyzing read counts from RNA-seq experiments. The voom
method estimates the mean-variance relationship of the log-counts, generates a precision weight for each
observation and enters these into the limma empirical Bayes analysis pipeline. This opens access for RNA-seq analysts
to a large body of methodology developed for microarrays. Simulation studies show that voom performs as well or
better than count-based RNA-seq methods even when the data are generated according to the assumptions of the
earlier methods. Two case studies illustrate the use of linear modeling and gene set testing methods.
Background
Gene expression profiling is one of the most commonly
used genomic techniques in biological research. For most
of the past 16 years or more, DNA microarrays have been
the premier technology for genome-wide gene expression
experiments, and a large body of mature statistical meth-
ods and tools has been developed to analyze intensity
data from microarrays. This includes methods for differ-
ential expression analysis [1-3], random effects [4,5], gene
set enrichment [6], gene set testing [7,8] and so on. One
popular differential expression pipeline is that provided
by the limma software package [9]. The limma pipeline
includes linear modeling to analyze complex experiments
with multiple treatment factors, quantitative weights to
account for variations in precision between different
observations, and empirical Bayes statistical methods to
borrow strength between genes.
Borrowing information between genes is a crucial fea-
ture of the genome-wide statistical methods, as it allows
for gene-specific variation while still providing reliable
inference with small sample sizes. The normal-based
empirical Bayes statistical procedures can adapt to differ-
ent types of datasets and can provide exact type I error
rate control even for experiments with a small number of
replicate samples [3].
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In the past few years, RNA-seq has emerged as a rev-
olutionary new technology for expression profiling [10].
One common approach to summarize RNA-seq data
is to count the number of sequence reads mapping to
each gene or genomic feature of interest [11-14]. RNA-
seq profiles consist therefore of integer counts, unlike
microarrays, which yield intensities that are essentially
continuous numerical measurements. A number of early
RNA-seq publications applied statistical methods devel-
oped for microarrays to analyze RNA-seq read counts.
For example, the limma package has been used to ana-
lyze log-counts after normalization by sequencing depth
[11,15-17].
Later statistical publications argued that RNA-seq data
should be analyzed by statistical methods designed specif-
ically for counts. Much interest has focused on the nega-
tive binomial (NB) distribution as a model for read counts,
and especially on the problem of estimating biological
variability for experiments with small numbers of repli-
cates. One approach is to fit a global value or global trend
to theNB dispersions [13,18,19], although this has the lim-
itation of not allowing for gene-specific variation. A num-
ber of empirical Bayes procedures have been proposed to
estimate the gene-wise dispersions [20-22]. Alternatively,
Lund et al. [23] proposed that the residual deviances from
NB generalized linear models be entered into limma’s
empirical Bayes procedure to enable quasi-likelihood test-
ing. Other methods based on over-dispersed Poisson
models have also been proposed [24-26].
Unfortunately, the mathematical theory of count dis-
tributions is less tractable than that of the normal distribution,
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and this tends to limit both the performance and the
usefulness of the RNA-seq analysis methods. One prob-
lem relates to error rate control with small sample sizes.
Despite the use of probabilistic distributions, all the sta-
tistical methods developed for RNA-seq counts rely on
approximations of various kinds. Many rely on the statis-
tical tests that are only asymptotically valid or are theoret-
ically accurate only when the dispersion is small. All the
differential expression methods currently available based
on the NB distribution treat the estimated dispersions as
if they were known parameters, without allowing for the
uncertainty of estimation, and this leads to statistical tests
that are overly liberal in some situations [27,28]. This is
true even of the NB exact test [18], which gives exact
type I error rate control when the dispersion is known but
which becomes liberal when an imprecise dispersion esti-
mator is inserted for the known value. Quasi-likelihood
methods [23] account for uncertainty in the dispersion by
using an F-test in place of the usual likelihood ratio test,
but this relies on other approximations, in particular that
the residual deviances are analogous to residual sums of
squares from a normal analysis of variance.
A related issue is the ability to adapt to different types
of data with high or low dispersion heterogeneity. None of
the empirical Bayes methods based on theNB distribution
achieve the same adaptability, robustness or small sample
properties as the correspondingmethods for microarrays,
due to the mathematical intractability of count distribu-
tions compared to the normal distribution.
Themost serious limitation though is the reduced range
of statistical tools associated with count distributions
compared to the normal distribution. This is more fun-
damental than the other problems because it limits the
types of analyses that can be done. Much of the statisti-
cal methodology that has been developed for microarray
data relies on use of the normal distribution. For exam-
ple, we often find it useful in our own microarray gene
expression studies to estimate empirical quality weights
to downweight poor quality RNA samples [29], to use
random effects to allow for repeated measures on the
same experimental units [4,5] or to conduct gene set
tests for expression signatures while allowing for inter-
gene correlations [7,8]. These techniques broaden the
range of experimental designs that can be analyzed or
offer improved interpretation for differential expression
results in terms of higher level molecular processes. None
of these techniques are currently available for RNA-seq
analysis using count distributions.
For these reasons, the purpose of this article is to revisit
the idea of applying normal-based microarray-like statis-
tical methods to RNA-seq read counts. An obstacle to
applying normal-based statistical methods to read counts
is that the counts have markedly unequal variabilities,
even after log-transformation. Large counts have much
larger standard deviations than small counts. While a log-
arithmic transformation counteracts this, it overdoes the
adjustment somewhat so that large log-counts now have
smaller standard deviations than small log-counts. We
explore the idea that it is more important to model the
mean-variance relationship correctly than it is to specify
the exact probabilistic distribution of the counts. There
is a body of theory in the statistical literature showing
that correct modeling of the mean-variance relationship
inherent in a data generating process is the key to design-
ing statistically powerful methods of analysis [30]. Such
variance modeling may in fact take precedence over iden-
tifying the exact probability law that the data values follow
[31-33]. We therefore take the view that it is crucial to
understand the way in which the variability of RNA-seq
read counts depends on the size of the counts. Our work
is in the spirit of pseudo-likelihoods [32] whereby statisti-
cal methods based on the normal distribution are applied
after estimating a mean-variance function for the data at
hand.
Our approach is to estimate the mean-variance rela-
tionship robustly and non-parametrically from the data.
We work with log-counts normalized for sequence depth,
specifically with log-counts per million (log-cpm). The
mean-variance is fitted to the gene-wise standard devia-
tions of the log-cpm as a function of average log-count.
We explore two ways to incorporate the mean-variance
relationship into the differential expression analysis. The
first is to modify limma’s empirical Bayes procedure to
incorporate a mean-variance trend. The second method
incorporates the mean-variance trend into a precision
weight for each individual normalized observation. The
normalized log-counts and associated precision weights
can then be entered into the limma analysis pipeline, or
indeed into any statistical pipeline for microarray data
that is precision weight aware. We call the first method
limma-trend and the second method voom, an acronym
for ‘variance modeling at the observational level’. limma-
trend applies the mean-variance relationship at the gene
level whereas voom applies it at the level of individual
observations.
This article compares the performance of the limma-
based pipelines to edgeR [20,34], DESeq [13], baySeq [21],
TSPM [25], PoissonSeq [26] and DSS [22], all of which
are based on NB or over-dispersed Poisson distributions.
Simulation studies show that the limma pipelines perform
at least as well in terms of power and error rate control
as the NB or Poisson methods even when the data is gen-
erated according to the probabilistic assumptions of the
earlier methods. A key advantage of the limma pipelines
is that they provide accurate type I error rate control even
when the number of RNA-seq samples is small. The NB
and Poisson based methods either fail to control the error
correctly or are excessively conservative. limma-trend and
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voom perform almost equally well when the sequencing
depths are the same for each RNA sample. When the
sequencing depths are different, voom is the clear best
performer.
Either voom or limma-trend give RNA-seq analysts
immediate access to many techniques developed for
microarrays that are not otherwise available for RNA-
seq, including all the quality weighting, random effects
and gene set testing techniques mentioned above. This
article presents two case studies that demonstrate how
voom can handle heterogeneous data and complex exper-
iments as well as facilitating pathway analysis and gene set
testing.
Results
Counts permillion: a simple interpretable scale
for assessing differential expression
We suppose that RNA-seq profiles (or libraries) are avail-
able for a set of n RNA samples. Each profile records
the number of sequence reads from that sample that
have been mapped to each one of G genomic features. A
genomic feature can be any predefined subset of the tran-
scriptome, for example a transcript, an exon or a gene.
For simplicity, we will assume throughout this article that
reads have been summarized by gene, so that the RNA-seq
profiles give the number of reads from each sample that
have been mapped to each gene. Typically G is large, in
the tens of thousands or more, whereas n can be as low as
three. The total number of mapped reads (library size) for
each sample might vary from a few hundred thousand to
hundreds of millions. This is the same context as assumed
by a number of previous articles [13,18,20,21,34].
The number of reads observed for a given gene is pro-
portional not just to the expression level of the gene but
also to its gene transcript length and to the sequencing
depth of the library. Dividing each read count by the cor-
responding library size (in millions) yields counts per mil-
lion (cpm), a simple measure of read abundance that can
be compared across libraries of different sizes. Standard-
izing further by transcript length (in kilobases) gives rise
to reads per kilobase per million (rpkm), a well-accepted
measure of gene expression [35]. In this article we will
work with the simpler cpm rather than rpkm, because we
are interested in relative changes in expression between
conditions rather than absolute expression.
This article treats log-cpm as analogous to log-intensity
values from a microarray experiment, with the difference
that log-cpm values cannot be treated as having constant
variances. Differences in log-cpm between samples can be
interpreted as log-fold-changes of expression. The counts
are augmented by a small positive value (a half of one
read) to avoid taking the logarithm of zero. This ensures
no missing log-cpm values and reduces the variability at
low count values.
Log-cpms have stabilized variances at high counts
Probability distributions for counts are naturally het-
eroscedastic, with larger variances for larger counts. It
has previously been argued that the mean-variance rela-
tionship for RNA-seq counts should be approximately
quadratic [34]. This leads to the conclusion that the coef-
ficient of variation (CV) of RNA-seq counts should be
a decreasing function of count size for small to moder-
ate counts but for larger counts should asymptote to a
value that depends on biological variability. Specifically,
the squared CV of the counts should be roughly
1/λ + φ
where λ is the expected size of the count and φ is a
measure of biological variation [34]. The first term arises
from the technical variability associated with sequenc-
ing, and gradually decreases with expected count size,
while biological variation remains roughly constant. For
large counts, the CV is determined mainly by biological
variation.
A simple linearization calculation suggests that the stan-
dard deviation of the log-cpm should be approximately
equal to the CV of the counts (seeMaterials andmethods).
Examination of a wide range of real datasets confirms
these expectations. For studies where the replicates are
entirely technical in nature, the standard deviation of the
log-cpm decreases steadily as a function of the mean
(Figure 1a). For studies where the replicates are genetically
identical mice, the standard deviation asymptotes at a
moderate level corresponding to a biological CV of about
10% (Figure 1b). Studies where the replicates are unrelated
human individuals show greater biological variation. For
these studies, the standard deviation asymptotes early and
at a relatively high level (Figure 1d).
We conclude that log-cpm values generally show a
smoothly decreasingmean-variance trend with count size,
and that the log-cpm transformation roughly de-trends
the variance of the RNA-seq counts as a function of count
size for genes with larger counts.
Using log-cpm in a limma pipeline
A simple approach to analyzing RNA-seq data would be to
input the log-cpm values into a well-established microar-
ray analysis pipeline such as that provided by the limma
software package [3,9]. This would be expected to behave
well if the counts were all reasonably large, but it ignores
the mean-variance trend for lower counts. The microar-
ray pipeline should behave better if modified to include
a mean-variance trend as part of the variance model-
ing. We have therefore modified the empirical Bayes
procedure of the limma package so that the gene-wise
variances are squeezed towards a global mean-variance
trend curve instead of towards a constant pooled variance.
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Figure 1Mean-variance relationships. Gene-wise means and variances of RNA-seq data are represented by black points with a LOWESS trend.
Plots are ordered by increasing levels of biological variation in datasets. (a) voom trend for HBRR and UHRR genes for Samples A, B, C and D of the
SEQC project; technical variation only. (b) C57BL/6J and DBA mouse experiment; low-level biological variation. (c) Simulation study in the presence
of 100 upregulating genes and 100 downregulating genes; moderate-level biological variation. (d) Nigerian lymphoblastoid cell lines; high-level
biological variation. (e) Drosophila melanogaster embryonic developmental stages; very high biological variation due to systematic differences
between samples. (f) LOWESS voom trends for datasets (a)–(e). HBRR, Ambion’s Human Brain Reference RNA; LOWESS, locally weighted regression;
UHRR, Stratagene’s Universal Human Reference RNA.
This is similar in principle to the procedure proposed by
Sartor et al. [36] for microarray data, except that wemodel
the trend using a regression spline and our implementa-
tion allows for the possibility of missing values or differing
residual degrees of freedom between genes. We call this
strategy limma-trend, whereby the log-cpm values are
analyzed as for microarray data but with a trended prior
variance. For comparison, the more naive approach with-
out themean-variance trend will be called limma-notrend.
voom: variance modeling at the observation-level
The limma-trend pipeline models the variance at the gene
level. However, in RNA-seq applications, the count sizes
may vary considerably from sample to sample for the same
gene. Different samples may be sequenced to different
depths, so different count sizesmay be quite different even
if the cpm values are the same. For this reason, we wish
to model the mean-variance trend of the log-cpm values
at the individual observation level, instead of applying a
gene-level variability estimate to all observations from the
same gene.
Our strategy is to estimate non-parametrically the
mean-variance trend of the logged read counts and to
use this mean-variance relationship to predict the vari-
ance of each log-cpm value. The predicted variance is then
encapsulated as an inverse weight for the log-cpm value.
When the weights are incorporated into a linear modeling
procedure, the mean-variance relationship in the log-cpm
values is effectively eliminated.
A technical difficulty is that we want to predict the
variances of individual observations although there is, by
definition, no replication at the observational level from
which variances could be estimated. We work around this
inconvenience by estimating the mean-variance trend at
the gene level, then interpolating this trend to predict the
variances of individual observations (Figure 2).
The algorithm proceeds as follows. First, gene-wise lin-
ear models are fitted to the normalized log-cpm values,
taking into account the experimental design, treatment
conditions, replicates and so on. This generates a resid-
ual standard deviation for each gene (Figure 2a). A robust
trend is then fitted to the residual standard deviations
as a function of the average log-count for each gene
(Figure 2b).
Also available from the linear models is a fitted value
for each log-cpm observation. Taking the library sizes
into account, the fitted log-cpm for each observation is
converted into a predicted count. The standard deviation
trend is then interpolated to predict the standard devia-
tion of each individual observation based on its predicted
count size (Figure 2c). Finally, the inverse squared pre-
dicted standard deviation for each observation becomes
the weight for that observation.
The log-cpm values and associated weights are then
input into limma’s standard differential expression
pipeline. Most limma functions are designed to accept
quantitative weights, providing the ability to perform
microarray-like analyses while taking account of the
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Figure 2 voommean-variance modeling. (a) Gene-wise square-root residual standard deviations are plotted against average log-count. (b) A
functional relation between gene-wise means and variances is given by a robust LOWESS fit to the points. (c) The mean-variance trend enables
each observation to map to a square-root standard deviation value using its fitted value for log-count. LOWESS, locally weighted regression.
mean-variance relationship of the log-cpm values at the
observation level.
voom and limma-trend control the type I error rate
correctly
We have found that voom and limma-trend, especially
voom, perform well and produce P values that control
error rates correctly over a wide range of simulation
scenarios. For illustration, we present results from sim-
ulations in which read counts were generated under the
same NBmodel as assumed by a number of existing RNA-
seq analysis methods. These simulations should represent
the ideal for the NB-based methods. If the normal-based
methods can give performance comparable to or better
than count-based methods in these simulations, then this
is strong evidence that they will be competitive across a
wide range of data types.
Six RNA-seq count libraries were simulated with counts
for 10,000 genes. The first three libraries were treated as
group 1 and the others as group 2. The distribution of
cpm values for each library was simulated to match the
distribution that we observed for a real RNA-seq dataset
from our own practice. The NB dispersion φ was set to
decrease on average with expected count size, asymp-
toting to 0.2 squared for large counts. This degree of
biological variation is representative of what we observe
for real RNA-seq data, being larger than we typically
observe between genetically identical laboratory mice but
less than we typically see between unrelated human sub-
jects (Figure 1). An individual dispersion φ was generated
for each gene around the trend according to an inverse
chi-square distribution with 40 degrees of freedom. The
voommean-variance trend for one such simulated dataset
is shown in Figure 1c. It can be seen from Figure 1 that
the simulated dataset is intermediate between the mouse
data (Figure 1b) and the human data (Figure 1d) both in
terms of the absolute size of the dispersions and in terms
of heterogeneity of the dispersions between genes.
We found that variation in sequencing depth between
libraries had a noticeable impact on some RNA-seq anal-
ysis methods. Hence all the simulations were repeated
under two library size scenarios, one with the same
sequencing depth for all six libraries and one with sub-
stantial variation in sequencing depth. In the equal size
scenario, all libraries were simulated to contain 11 million
reads. In the unequal size scenario, the odd-numbered
libraries were simulated to have a sequence depth of 20
million reads while the even-numbered libraries had a
sequence depth of 2 million reads. Hence the same total
number of reads was simulated in this scenario but dis-
tributed unevenly between the libraries.
In the first set of simulations, we examined the ability of
voom and limma-trend to control the type I error rate cor-
rectly in the absence of any genuine differential expression
between the groups.When there are no truly differentially
expressed genes, the gene-wise P values should follow an
approximate uniform distribution. If the type I error rate
is controlled correctly, then the expected proportion of
P values below any cutoff should be less than or equal
to the cutoff value. A number of popular RNA-seq anal-
ysis methods based on the NB or Poisson distributions
were included for comparison. Figure 3 shows results for
a P value cutoff of 0.01. Results for other cutoffs are
qualitatively similar. None of the NB- or Poisson-based
methods were found to control the type I error rate very
accurately. When the library sizes are equal, the NB and
Poisson methods were overly liberal, except for DESeq
which is very conservative. When the library sizes are
unequal, DSS and DESeq became extremely conservative.
By contrast, all the normal-based methods were slightly




























































































































(b) Unequal library sizes
Figure 3 Type I error rates in the absence of true differential expression. The bar plots show the proportion of genes with P < 0.01 for each
method (a) when the library sizes are equal and (b)when the library sizes are unequal. The red line shows the nominal type I error rate of 0.01.
Results are averaged over 100 simulations. Methods that control the type I error at or below the nominal level should lie below the red line.
conservative. voom produces results very close to the
nominal type I error rate for both library size scenarios.
limma-trend is similar to voom when the library sizes are
equal but somewhat conservative when the library sizes
are unequal.
baySeq was not included in the type I error rate com-
parison because it does not return P values. However, the
results presented in the next section show that it is rel-
atively conservative in terms of the false discovery rate
(FDR) (Figure 4).
To check voom’s conservativeness on real data, we used
a set of four replicate libraries from the SEQC Project [37].
All four libraries were Illumina HiSeq 2000 RNA-seq pro-
files of samples of Ambion’s Human Brain Reference RNA
(HBRR) [38]. We split the four libraries into two groups
in all possible ways, and tested for differential expression
between the two groups for each partition. voom returned
no differentially expressed (DE) genes at 5% FDR for six
out of the seven possible partitions, indicating good error
rate control. The voommean-variance trend for the SEQC
data, using all the libraries rather than the HBRR samples
only, is shown in Figure 1a.
voom has the best power of methods that control the type
I error rate
Next we examined the power to detect true differential
expression. For the following simulations, 100 randomly
selected genes were twofold upregulated in the first group
and another 100 were twofold upregulated in the second
group. This represents a typical scenario for a functional
genomics experiment in which the differential expression
effects are large enough to be biologically important but
nevertheless sufficiently subtle as to challenge many anal-































































































































(b) Unequal library sizes
Figure 4 Power to detect true differential expression. Bars show the total number of genes that are detected as statistically significant (FDR <
0.1) (a)with equal library sizes and (b)with unequal library sizes. The blue segments show the number of true positives while the red segments
show false positives. 200 genes are genuinely differentially expressed. Results are averaged over 100 simulations. Height of the blue bars shows
empirical power. The ratio of the red to blue segments shows empirical FDR. FDR, false discovery rate.
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false discoveries made by various analysis methods at
significance cutoff FDR < 0.1. When the library sizes are
equal, voom and limma-trend have the next best power
after edgeR and PoissonSeq. However, both edgeR and
PoissonSeq give empirical FDRs greater than 0.1, confirm-
ing the results of the previous section that these methods
are somewhat liberal. limma-trend gives an empirical FDR
slightly greater than voom but still less than 0.1. With
unequal library sizes, voom has the best power except for
edgeR while still maintaining a low FDR. TSPM declares
by far the most DE genes, but these are mostly false dis-
coveries. DSS also gives a worryingly high rate of false
discoveries when the library sizes are unequal. Figures 3
and 4 together show that voomhas the best power of those
methods that correctly control the type I and FDR error
rates.
voom has the lowest false discovery rate
Next we compared methods from a gene ranking point
of view, comparing methods in terms of the number of
false discoveries for any given number of genes selected
as DE. Methods that perform well will rank the truly DE
genes in the simulation ahead of non-DE genes. Genes
were ranked by posterior likelihood for baySeq and by
P value for the other methods. The results show that
voom has the lowest FDR at any cutoff (Figure 5). When
the library sizes are equal, limma-trend and PoissonSeq
are very close competitors (Figure 5a). When the library
sizes are unequal, limma-trend and edgeR are the closest
competitors (Figure 5b).
Next we compared FDRs using spike-in control tran-
scripts from the SEQC project [39]. The data consists of
eight RNA-seq libraries, in two groups of four. A total of
92 artificial control transcripts were spiked-in at different
concentrations in such a way that three quarters of the
transcripts were truly DE and the remaining quarter were
not. To make the spike-ins more like a realistic dataset,
we replicated the counts for each of the 23 non-DE tran-
scripts three times. That is, we treated each non-DE
transcript as three different transcripts. This resulted in a
dataset of 138 transcripts with half DE and half non-DE.
Figure 6 is analogous to Figure 5 but using the spike-in
data instead of simulated data. voom again achieved the
lowest FDR, with edgeR and the other limma methods
again being the closest competitors (Figure 6).
voom and limma-trend are faster than specialist RNA-seq
methods
The different statistical methods compared varied con-
siderably in computational time required, with DESeq,
TSPM and baySeq being slow enough to limit the number
of simulations that were done. voom is easily the fastest
of the methods compared, with edgeR-classic next fastest
(Figure 7).
RNA-seq profiles of male and female Nigerian individuals
So far we have demonstrated the performance of voom
on RNA-seq datasets with small numbers of replicate
libraries. To demonstrate the performance of voom on
a heterogeneous dataset with a relatively large num-
ber of replicates and a high level of biological vari-
ability, we compared males to females using RNA-seq
profiles of lymphoblastoid cell lines from 29 male and
40 female unrelated Nigerian individuals [40]. Summa-
rized read counts and gene annotation are provided
by the Bioconductor tweeDEseqCountData package [41].
Figure 1d shows the voom mean-variance trend of this
dataset.
voom yielded 16 genes upregulated in males and 43
upregulated in females at 5% FDR. As expected, most of
the top differentially expressed genes belonged to the X
or Y sex chromosomes (Table 1). The top gene is XIST,

























(b) Unequal library sizes
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Figure 5 False discovery rates. The number of false discoveries is plotted for each method versus the number of genes selected as differentially
expressed. Results are averaged over 100 simulations (a)with equal library sizes and (b)with unequal library sizes. voom has the lowest FDR at any
cutoff in either scenario. FDR, false discovery rate.
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Figure 6 False discovery rates evaluated from SEQC spike-in
data. The number of false discoveries is plotted for each method
versus the number of genes selected as differentially expressed.






















































Figure 7 Computing times of RNA-seq methods. Bars show time
in seconds required for the analysis of one simulated dataset on a
MacBook laptop. Methods are ordered from quickest to most
expensive.
which is a key player in X inactivation and is known to be
expressed at meaningful levels only in females.
We examined 12 particular genes that are known to
belong to the male-specific region of chromosome Y
[42,43].A ROAST gene set test confirmed that these genes
collectively are significantly upregulated in males (P =
0.0001). A CAMERA gene set test was even more con-
vincing, confirming that these genes are significantlymore
upregulated in males than are other genes in the genome
(P = 2 × 10−28).
We also examined 46 X chromosome genes that have
been reported to escape X inactivation [43,44]. These
genes were significantly upregulated in females (ROAST
P = 0.0001, CAMERA P = 10−10). The log-fold-changes
for the X and Y chromosome genes involved in the gene
set tests are highlighted on an MA plot (Figure 8).
Note that these gene set testing approaches are not
available for any of the count-based approaches to dif-
ferential expression. If a count-based method had been
used to assess differential expression, we could still have
examined whether sex-linked genes were highly ranked
among the differentially expressed genes, but we could not
have undertaken any formal statistical test for enrichment
of this signature while accounting for inter-gene corre-
lation. On the other hand, the voom expression values
and weights are suitable for input into the ROAST and
CAMERA procedures without any further processing.
Development stages of Drosophilamelanogaster
Like edgeR-glm, but unlike most other analysis tools,
voom and limma-trend offer full-featured linear modeling
for RNA-seq data, meaning that they can analyze arbitrary
complex experiments. The possibilities of linear modeling
are so rich that it is impossible to select a representa-
tive example. voom and limma could be used to analyze
any gene-level RNA-seq differential expression experi-
ment, including those with multiple experimental factors
[34]. Here we give a novel analysis illustrating the use of
quadratic regression to analyze a time-course study.
RNA-seq was used to explore the developmental tran-
scriptome of Drosophila melanogaster [45]. RNA-seq
libraries were formed from whole-animal samples to rep-
resent a large number of distinct developmental stages.
In particular, samples were collected from embryonic ani-
mals at equi-spaced development stages from 2 hours
to 24 hours in 2-hour intervals. Here we analyze the
12 RNA-seq libraries from these embryonic stages. We
sought to identify those genes that are characteristic of
each embryonic stage. In particular we wished to identify,
for each embryonic stage, those genes that achieve their
peak expression level during that stage.
As all the samples are from distinct stages, there are
no replicate libraries in this study. To estimate variances
we utilized the fact that gene expression should for most
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Table 1 Top 16 genes differentially expressed betweenmales and females in the Nigerian data
Ensembl ID Symbol Chr logFC AveExpr t P value FDR B
ENSG00000229807 XIST X -9.815 3.8084 -36.4 7.03e-48 1.19e-43 74.8
ENSG00000099749 CYorf15A Y 4.251 0.3146 28.3 1.25e-40 1.05e-36 68.2
ENSG00000157828 RPS4Y2 Y 3.281 3.3081 26.5 9.38e-39 5.27e-35 72.6
ENSG00000233864 TTTY15 Y 4.897 -0.5538 25.9 4.31e-38 1.82e-34 64.0
ENSG00000131002 CYorf15B Y 5.440 -0.1710 23.2 4.81e-35 1.62e-31 60.0
ENSG00000198692 EIF1AY Y 2.398 2.6806 20.5 1.09e-31 3.07e-28 58.6
ENSG00000165246 NLGN4Y Y 5.330 -0.4916 19.7 1.26e-30 3.03e-27 52.4
ENSG00000213318 RP11-331F4.1 16 4.293 2.2654 19.3 4.44e-30 9.34e-27 54.1
ENSG00000129824 RPS4Y1 Y 2.781 4.7118 17.6 9.28e-28 1.74e-24 51.5
ENSG00000183878 UTY Y 1.878 2.7430 16.6 2.88e-26 4.85e-23 47.7
ENSG00000012817 KDM5D Y 1.470 4.7046 14.9 1.45e-23 2.22e-20 42.6
ENSG00000146938 NLGN4X X 4.472 -0.7801 14.8 2.09e-23 2.94e-20 38.9
ENSG00000243209 AC010889.1 Y 2.528 -0.0179 14.5 5.48e-23 7.11e-20 37.9
ENSG00000067048 DDX3Y Y 1.671 5.3077 13.4 3.05e-21 3.67e-18 37.5
ENSG00000006757 PNPLA4 X -0.988 2.5341 -10.4 4.78e-16 5.38e-13 25.7
ENSG00000232928 RP13-204A15.4 X 1.434 3.2506 10.3 1.02e-15 1.08e-12 25.2
The table shows output from the limma topTable function. As well as gene ID and symbol, columns give chromosome location (Chr), log2-fold-change (logFC), average



















Figure 8MA plot of male vs female comparison with male- and
female-specific genes highlighted. The MA plot was produced by
the limma plotMA function, and is a scatterplot of log-fold-change
versus average log-cpm for each gene. Genes on the male-specific
region of the Y chromosome genes are highlighted blue and are
consistently upregulated in males, while genes on the X
chromosome reported to escape X inactivation are highlighted red
and are generally down in males. log-cpm, log-counts per million.
genes vary smoothly over time. A multidimensional scal-
ing plot of log-cpm values shows the gradual change
in gene expression during embryonic development, with
each stage intermediate in expression profile between the
stages before and after (Figure 9). We used gene-wise
linear models to fit a quadratic trend with time to the
log-cpm values for each gene. These quadratic trends will
not match all the intricacies of gene expression changes
over time but are sufficient to model the major trends.
The voom mean-variance trend for this data is shown in
Figure 1e.
Out of 14,869 genes that were expressed during embry-
onic development, 8,366 showed a statistically significant
trend at 5% FDR using empirical Bayes F-tests. For each
differentially expressed gene, we identified the embry-
onic stage at which the fitted quadratic trend achieved its
maximum value. This allowed us to associate each signifi-
cant gene with a particular development stage (Figure 10).
Most genes peaked at the first or last stage (Figure 10),
indicating smoothly decreasing or increasing trends over
time (Figure 11, panels 1 and 12). Genes peaking at
the first embryonic stage tended to be associated with
the cell cycle. Genes peaking at the last stage tended
to be associated with precursor metabolites and energy,
the oxidation-reduction process and with metabolic
pathways.
Genes peaking at intermediate stages have expression
trends with an inverse-U shape (Figure 11, panels 2–
11). There was a substantial set of genes with peak
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Figure 9Multidimensional scaling plot of Drosophila
melanogaster embryonic stages. Distances are computed from the
log-cpm values. The 12 successive embryonic developmental stages
are labeled 1 to 12, from earliest to latest.
activity between 12–16 hours of embryonic development
(Figure 10), suggesting some important developmental
change occurring during this period requiring the action
of special-purpose genes. Indeed, gene ontology analysis
of the genes associated with this period showed that
anatomical structure morphogenesis was the most signif-
icantly enriched biological process. Other leading terms




























































Figure 10 Number of genes associated with each Drosophila
melanogaster embryonic stage. The number of genes whose peak
estimated expression occurs at each of the stages is recorded.
This analysis demonstrates a simple but effective means
of identifying genes that have a particular role at each
developmental stage.
Discussion
This article follows the common practice of examining dif-
ferential expression on a gene-wise basis. Our preferred
practice is to count the total number of reads overlap-
ping annotated exons for each genes. While this approach
does not allow for the possibility that different isoforms of
the same gene may be differentially expressed in different
directions, it does provide a statistically robust gene-level
analysis even when the sequencing depths are quite mod-
est. The relevance of gene-level analyses is also supported
by recent surveys of transcription, which have shown that
each gene tends to have a dominant isoform that accounts
for far more of the total expression for that gene than any
of the remaining isoforms [46,47]. The voom analysis can
also be conducted at the exon level instead of at the gene
level as an aid to detecting alternative splicing between the
treatment groups.
In this article, voom has been applied to log-cpm val-
ues. voom can work, however, just as easily with logged
rpkm values in place of log-cpm, because the precision
weights are the same for both measures. If the genomic
length of each gene is known, then the log-cpm values out-
put by voom can be converted to log-rpkm by subtracting
the log2 gene length in kilobases. The downstream analy-
sis is unchanged and will yield identical results in terms of
differentially expressed genes and estimated fold-changes.
This article has shown that a normal-based analysis
of RNA-seq read count data performs surprisingly well
relative to methods that use special-purpose count dis-
tributions. The motivation for examining normal-based
methods was to open up access to a range of microarray-
like analysis tools based on the normal distribution. From
this point of view, the normal-based methods only need
to perform comparably to the count-based methods in
terms of power and FDR control in order to be a success.
Our comparisons suggest not only that this is so, but that
the normal-based methods actually have a performance
advantage. We found voom to be the best performer
across our simulations and comparisons, and even the
simpler limma-trend method performed equal or better
than the count-based methods. voom and limma-trend
perform almost equally when the library sizes are equal,
but voom has the advantage when the library sizes are
unequal. The best performing count-based methods were
edgeR and PoissonSeq, although neither of those meth-
ods controlled the type I error rate at the nominal level,
both being somewhat liberal. The performance advan-
tage of voom over many of the count-based methods was
quite substantial in our simulations, despite the simula-
tions being conducted under the same NB distributional
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Figure 11 Expression trends for genes that peak at each Drosophila melanogaster embryonic stage. Panels (1) to (12) correspond to the 12
successive developmental stages. Each panel displays the fitted expression trends for the top ten genes that achieve their peak expression during
that stage. In particular, panel (1) shows genes that are most highly expressed at the first stage and panel (12) shows genes most highly expressed
at the last stage. Panels (7) and (8) are notable because they show genes with marked peaks at 12–14 hours and 14–16 hours respectively.
assumptions as made by a number of existing methods.
Other simulation scenarios would tend to increase voom’s
advantage. For example, it would be at least as scien-
tifically reasonable to assume that the true expression
levels for each gene follow a log-normal distribution
between replicates instead of a gamma distribution, and
such an assumption would tend to improve the perfor-
mance of voom relative to edgeR, DESeq, baySeq and
DSS. In general, voommakes fewer distributional assump-
tions than do competing methods and can therefore be
expected to perform robustly across a range of scenar-
ios. This study presented simulations with equal library
sizes between replicates, and also explored the sensitivity
of the methods to unequal library sizes. In our expe-
rience markedly unequal library sizes can arise in real
RNA-seq experiments for a variety of reasons. One sce-
nario is when an experiment is conducted in stages and
samples sequenced at a later time have a much higher
sequencing depth. Other possible scenarios occur when
technical replicates are combined for a subset of samples
or when DNA samples are multiplexed onto a sequencing
lane in unequal quantities. Some of the NB-based anal-
ysis methods become very conservative or showed very
poor FDR control when the library sizes were unequal.
In contrast, voom shows consistent performance in all
scenarios.
The worst performer in our simulation was TSPM,
presumably because we have simulated from NB distribu-
tions, which have quadratic mean-variance relationships,
whereas TSPM assumes a linear mean-variance relation-
ship [25]. The second worst performer was the ordinary
t-test. This shows that traditional statistical methods can-
not be reliably applied to genomic data without borrowing
strength between genes. The third worst performer was
limma-notrend, showing that the mean-variance trend in
the log-cpm values cannot be ignored.
To examine sensitivity of the results to the shape of the
dispersion distribution, we repeated all the simulations
using a log-normal distribution for the gene-wise disper-
sions instead of an inverse chi-square distribution. The
two distributions were chosen to have the same mean
and variance on the log-scale. The results were virtually
unchanged from those shown in Figures 3, 4 and 5, show-
ing that the shape of the dispersion distribution is not a
major determination of performance. This agrees with a
similar conclusion in Wu et al. [22].
It may seem surprising at first that voom should per-
form so well even though it ignores the discrete integer
nature of the counts. We think there are several possible
reasons for this. First, the parametric advantages of the
Poisson or NB distributions are mitigated by the fact that
the observedmean-variance relationship of RNA-seq data
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does not perfectly match the theoretical mean-variance
relationships inherent in these distributions. While the
quadratic mean-variance relationship of the NB distribu-
tion captures most of the mean-variance trend, the NB
dispersion still shows a non-ignorable trend with gene
abundance [13,19,34]. This means that the mean-variance
relationship still has to be estimated non-parametrically,
at least in part.
Second, voom is more precise than previousmethods in
terms of its treatment of the mean-variance trend. While
several previous methods fit a semi-parametric trend to
the variances or to the NB dispersions [13,19,23,34], the
trend has always been used to estimate gene-level model
parameters. This ignores the fact that different counts for
the same gene may vary substantially in size, meaning
that the trend should be applied differently to different
observations. This consideration becomes more critical
when different RNA samples are sequenced to different
depths.
Third, the use of normal models gives voom access to
tractable empirical Bayes distribution theory [3], facili-
tating reliable estimation of the Bayesian hyperparam-
eters and exact small sample distributions for the test
statistics. Amongst other things this facilitates accurate
estimate of the prior degrees of freedom determining
the optimal amount of squeezing to be applied to the
variances.
Fourth, the use of normal distribution approxima-
tions in conjunction with variance modeling is partly
supported by generalized linear model theory. Rao’s
score test [48] for a covariate in a generalized linear
model is essentially equivalent to the normal theory
test statistic, provided that the mean-variance function
is correctly estimated and incorporated into appropriate
precision weights [49]. Score tests have similar perfor-
mance to likelihood ratio tests when the null hypothesis
is true or when the changes being detected are relatively
small.
Some of the count-based methods have been criticized
as being sensitive to outlier counts [28]. The voom and
limma-trend methods inherit good robustness properties
from the normal-based procedures in limma [28]. If nec-
essary, they can be made extremely robust to outliers
and hypervariable genes using the robust empirical Bayes
options of the limma package [50].
In addition to performance results, voom has a number
of qualitative advantages over the count-based methods.
It is fast and convenient. It allows RNA-seq and microar-
ray data to be analyzed in closely comparable ways, which
may be an attraction for analysts comparing results from
the two technologies. It gives access to a wealth of sta-
tistical methods developed for microarrays, including for
example the gene set testing methods demonstrated on
the Nigerian dataset.
Conclusions
voom performs as well or better than existing RNA-seq
methods, especially when the library sizes are unequal.
It is moreover faster and more convenient, and converts
RNA-seq data into a form that can be analyzed using
similar tools as for microarrays.
Materials andmethods
Log-counts permillion
We assume that an experiment has been conducted to
generate a set of n RNA samples. Each RNA sample has
been sequenced, and the sequence reads have been sum-
marized by recording the number mapping to each gene.
The RNA-seq data consist therefore of a matrix of read
counts rgi, for RNA samples i = 1 to n, and genes g = 1
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The counts are offset away from zero by 0.5 to avoid tak-
ing the log of zero, and to reduce the variability of log-cpm
for low expression genes. The library size is offset by 1 to
ensure that (rgi +0.5)/(Ri +1) is strictly less than 1 as well
as strictly greater than zero.
Delta rule for log-cpm
Write λ = E(r) for the expected value of a read count
given the experimental conditions, and suppose that:
var(r) = λ + φλ2
where φ is a dispersion parameter. If r is large, then the
log-cpm value of the observation is:
y ≈ log2(r) − log2(R) + 6 log2(10)
where R is the library size. Note that the analysis is con-
ditional on R, so R is treated as a constant. It follows that
var( y) ≈ var(log2(r). If λ also is large, then:
log2(r) ≈ λ +
r − λ
λ
by Taylor’s theorem [51], so:






This article develops differential expression methods for
RNA-seq experiments of arbitrary complexity, for exam-
ple experiments with multiple treatment factors, batch
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effects or numerical covariates. As has been done pre-
viously [3,7,8,34], we use linear models to describe how
the treatment factors are assigned to the different RNA
samples. We assume that:
E( ygi) = μgi = xTi βg
where xi is a vector of covariates and βg is a vector
of unknown coefficients representing log2-fold-changes
between experimental conditions. In matrix terms:
E( yg) = Xβg
where yg is the vector of log-cpm values for gene g and X
is the designmatrix with the xi as rows. Interest centers on
testing whether one or more of the βgj are equal to zero,
voom variance modeling
The above linear model is fitted, by ordinary least squares,
to the log-cpm values ygi for each gene. This yields regres-
sion coefficient estimates βˆg , fitted values μˆgi = xTi βˆg and
residual standard deviations sg .
Also computed is the average log-cpm y¯g for each gene.
The average log-cpm is converted to an average log-count
value by:
r˜ = y¯g + log2(R˜) − log2(106)
where R˜ is the geometric mean of the library sizes plus
one.
To obtain a smooth mean-variance trend, a LOWESS
curve is fitted to square-root standard deviations s1/2g as a
function of mean log-counts r˜ (Figure 2a,b). Square-root
standard deviations are used because they are roughly
symmetrically distributed. The LOWESS curve [52] is sta-
tistically robust [53] and provides a trend line through
the majority of the standard deviations. The LOWESS
curve is used to define a piecewise linear function lo() by
interpolating the curve between ordered values of r˜.
Next the fitted log-cpm values μˆgi are converted to fitted
counts by:
λˆgi = μˆgi + log2(Ri + 1) − log2(106).
The function value lo(λˆgi) is then the predicted square-
root standard deviation of ygi.
Finally, the voom precision weights are the inverse vari-
ances wgi = lo(λˆgi)−4 (Figure 2c). The log-cpm values
ygi and associated weights wgj are then input into limma’s
standard linear modeling and empirical Bayes differential
expression analysis pipeline.
Gene set testingmethods
ROAST [7] and CAMERA [8] are gene set testing pro-
cedures that assess changes in the overall expression
signature defined by a set of genes. ROAST [7] is a self-
contained test that assesses differential expression of the
gene set without regard to genes not in the set. CAMERA
[8] is a competitive test that assesses differential expres-
sion of the gene set relative to all other genes on the array.
Both procedures offer considerable flexibility as they have
the ability to test the association of a genomic pathway or
gene set signature with quite general treatment compar-
isons or contrasts defined in the context of a microarray
linear model. We have adapted both methods to make use
of quantitative weights as output by voom. The revised
methods are implemented in the functions roast() and
camera() of the limma software package.
Normalization
The log-cpm values are by definition normalized for
sequencing depth. Other normalization steps can option-
ally be done. The library sizes Ri can be scale nor-
malized to adjust for compositional differences between
the RNA-seq libraries [54]. This produces normalized
library sizes R∗i that can be used in place of Ri in the
voom pipeline. Alternatively, between-array normaliza-
tion methods developed for single channel microarray
data, such as quantile or cyclic LOESS, can be are applied
to the log-cpm values.
Simulations
The simulations were designed to generate data with char-
acteristics similar to real data that we analyze in our
own practice. First a set of baseline expression values was
generated representing the relative proportion of counts
expected to arise from each gene. These proportions were
translated into expected count sizes by multiplying by
library size, and then multiplied by true fold-changes as
appropriate. Counts were then generated following a NB
distribution with the specified mean and dispersion for
each observation.
The distribution of baseline values was chosen to match
that from RNA-seq experiments conducted at our insti-
tution. Specifically we used the goodTuringProportions
function of the edgeR package [12], which implements the
Good-Turing algorithm [55], to predict the true propor-
tion of total RNA attributable to each gene. We ran this
function on a number of different libraries, pooled the
predicted proportions and formed a smoothed distribu-
tion function. The baseline proportions for the simula-
tions were then generated to follow this distribution.
The NB dispersions were generated as follows. The
trend in the dispersions was set to be ψgi with:
ψ
1/2
gi = 0.2 + λ−1/2gi
where λgi is the expected count size. A modest amount
of gene-wise biological variation was generated from an
inverse chi-square distribution with 40 degrees of free-
dom. The individual dispersions were set to be φgi = ψgiδg
where 40/δg ∼ χ240.
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In an alternative simulation, to investigate sensitivity to
the distribution of gene-wise dispersions, the δg were sim-
ulated as log-normal with mean 0 and standard deviation
0.25 on the log-scale. This produces a distribution with a
similar CV as for the inverse chi-square simulation.
For each simulated dataset, genes with less than ten
reads across all samples were filtered from the analysis.
PoissonSeq resets the seed of the random number genera-
tor in R, so it was necessary to save and restore the state of
the random number generator before and after each call
of the main PoissonSeq function.
Complete runnable code that reproduces all the simu-
lations is provided as Additional file 1. See also the voom
website [56].
SEQC data
The SEQC project, also known as MAQC-III, aims
to provide a comprehensive study of next-generation
sequencing technologies [37]. We analyze here a pilot
SEQC dataset consisting of 16 RNA-seq libraries in four
groups. The full SEQC data including the 16 libraries
analyzed here will become available as GEO series
[GEO:GSE47792] when the main SEQC article is pub-
lished in 2014. In the meantime, the aligned and summa-
rized read counts for the pilot libraries needed to repeat
the analyses in this article are available from the voom
webpage [56].
The groups are labeled A–D and are closely analogous
to the similarly labeled RNA samples used in the earlier
microarray quality control study [57]. Libraries in group
A are profiles of Stratagene’s Universal Human Reference
RNA (UHRR) with the addition of RNA from Ambion’s
ERCC ExFold RNA spike-in mix 1 (Mix 1). Libraries in
group B are profiles of Ambion’s Human Brain Refer-
ence RNA (HBRR) with added RNA fromAmbion’s ERCC
ExFold RNA spike-in mix 2 (Mix 2). RNA samples in
groups C and D are mixtures of A and B in the proportions
75:25 and 25:75, respectively. An Illumina HiSeq 2000 was
used to create a FastQ file of paired-end sequence reads
for each sample. The library size for each sample varied
from 5.4 to 8.0million read pairs. Fragments weremapped
to the National Center for Biotechnology Information’s
Build 37.2 of the human genome using the Subread aligner
[58]. Fragment counts were summarized by Entrez Gene
ID using the featureCounts function [59] of version 1.8.2
of the Bioconductor package Rsubread [60]. Fragments
with both end reads mapped successfully contributed one
count if the fragment overlapped any annotated exon for
that gene. Fragments for which only one readmapped suc-
cessfully contributed half a count if that read overlapped
an exon. The summarized read count data is available
from the voom webpage [56].
The voom mean-variance trend shown in Figure 1a was
obtained from all 16 libraries, treated as four groups.
Genes were filtered out if they failed to achieve cpm > 1
in at least four libraries, and the remaining log-cpm values
were quantile normalized between libraries [61].
The comparison between technical replicates to check
the type I error rate control used only the four group B
libraries. Genes were filtered out if they failed to achieve
a cpm > 1 in at least two libraries and the log-cpm values
for the 16,745 remaining genes were quantile normalized.
Samples were separated into all possible two-versus-two
and three-versus-one combinations and a limma analysis
using voom weights was carried out for each partition.
The false discovery rate analysis was conducted on the
spike-in transcripts only. ERCC Mixes 1 and 2 contain 92
transcripts spiked in at different concentrations. For this
analysis, fragments were mapped to the known sequences
of the spiked-in transcripts using Subread. The experi-
ment is designed so that 23 transcripts have the same
concentration in Mix 1 and Mix 2. The remaining tran-
scripts were spiked-in in such a way that 23 transcripts are
fourfold more abundant in Mix 1, 23 are 1.5 higher in Mix
2 and 23 are twofold higher in Mix 2. A majority of the
spike-in transcripts data are DE. We replicated the counts
for each of the 23 non-DE transcripts three times, so
that each non-DE transcript was treated as three different
transcripts. This resulted in a dataset of 138 transcripts,
half DE and half non-DE. Our analysis used read counts
for the spike-in transcripts only. TMM-scale normaliza-
tion [54] was used for all the analysis methods, except
for DESeq and PoissonSeq, which have their own built-
in normalization methods. No transcripts were filtered,
except by PoissonSeq as its standard analysis includes the
removal of probes with low counts. The genes that were
filtered out by PoissonSeq were re-introduced to the end
of the gene ranking, ordered from largest mean count to
lowest mean count.
Lymphoblastoid cell lines from Nigerian individuals
As part of the International HapMap Project, RNA sam-
ples were obtained from lymphoblastoid cell lines derived
from 69 unrelated Nigerian individuals including 29males
and 40 females [40]. Sequencing was performed using
an Illumina Genome Analyzer II. Read counts, sum-
marized by Ensembl gene, and transcript annotations
were obtained from version 1.0.9 of the tweeDEseq-
CountData Bioconductor package [43], specifically from
the data objects pickrell1, annotEnsembl63 and
genderGenes. Genes were filtered if they failed to
achieve a cpm value of 1 in at least 20 libraries. Library
sizes were scale-normalized by the TMM method [54]
using edgeR software [12] prior to the voom analysis.
Development stages of Drosophilamelanogaster
RNA-seq was used to explore the developmental tran-
scriptome of D. melanogaster [45]. Mapped read counts
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are available from the ReCount project [62]. Specifically
the pooled version of the modencodefly dataset from the
ReCount website [63] provides read counts summarized
by Ensembl 61 gene IDs for 30 whole-animal biological
samples. We discarded the larval, pupal and adult stages
and kept only the 12 embryonic samples. Genes were
retained in the analysis if they achieved cpm > 1 for any
embryonic stage. Effective library sizes were estimated by
TMM scale-normalization [54] using edgeR software [12]
prior to the voom analysis.
Gene ontology analysis used the GOstats software pack-
age [64] and version 2.9.0 of the org.Dm.eg.db annotation
package [65]. All GO terms mentioned in the Results
section had Fisher’s exact test P values less than 10−10.
C57BL/6J and DBA/2J inbredmouse strains
An RNA-seq experiment was carried out to detect differ-
ential striatal gene expression between the C57BL/6J (B6)
and DBA/2J (D2) inbred mouse strains [66]. Profiles were
made for 10 B6 and 11 D2 mice. Mapped read counts
summarized by Ensembl 61 gene IDs were downloaded
as the bottomly dataset from the ReCount website [63].
Genes were filtered out if they failed to achieve cpm > 1
in at least four libraries and the remaining log-cpm val-
ues were quantile normalized. The limma-voom analysis
compared the two strains and included a batch effect cor-
rection for the Illumina flow cell in which each sample was
sequenced. The voom mean-variance trend is shown in
Figure 1b.
Software
The results presented in this article were obtained using
R version 3.0.0 and the software packages limma 3.16.2,
edgeR 3.2.3, baySeq 1.14.1, DESeq 1.12.0, DSS 1.4.0, Pois-
sonSeq 1.1.2 and tweeDEseqCountData 1.0.8. All of these
packages are part of the Bioconductor project [67,68],
except for PoissonSeq, which is part of the Comprehen-
sive R Archive Network [69]. The TSPM function, dated
February 2011, was downloaded in March 2013 from the
author’s webpage [70].
The voom methodology proposed in the article is
implemented in the voom function of the limma pack-
age. The limma-trend method was implemented by
inputting the log-cpm values from voom into limma’s
standard pipeline, with trend=TRUE for the eBayes
function. Hence the limma-trend pipeline was the same
as that for voom except that weights were not used
in the linear modeling step and the trend option was
turned on for the empirical Bayes step. The limma
package can be installed from the Bioconductor project
repository [71].
All the count-based packages were used with the
default differential expression pipelines as recommended
in the software for each package. For edgeR 3.2.3 the
default prior degrees of freedom for squeezing the gene-
wise dispersions is 10. Note that this is a change from
versions 3.0.X and earlier for which the default had
been 20. For DSS the Wald test was used as rec-
ommended in the documentation. The DESeq defaults
have changed considerably since the original publication.
We used the DESeq function estimateDispersions with
sharingMode="maximum" and fitType="local"
and conducted tests using nbinomTest.
The different count-based packages implement differ-
ent methods of compositional normalization [54]. For
our simulations, there are no compositional differences
between the libraries so there should be no need to esti-
mate compositional normalization factors. For this reason
we did not use the calcNormFactors function with edgeR
or estimateSizeFactors with DESeq or estNormFactors
withDSS. This should tend to improve the performance of
the packages and to make them more comparable, as any
differences between the packages can be attributed to the
statistical procedures rather than to differences between
the normalization strategies.
Additional file
Additional file 1: Simulation code. R code to reproduce the simulations
presented in Figures 3, 4 and 5.
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